Ada G. Blidner

1.3k total citations
30 papers, 899 citations indexed

About

Ada G. Blidner is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Ada G. Blidner has authored 30 papers receiving a total of 899 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Immunology, 15 papers in Oncology and 9 papers in Molecular Biology. Recurrent topics in Ada G. Blidner's work include Galectins and Cancer Biology (13 papers), Cancer Immunotherapy and Biomarkers (10 papers) and CAR-T cell therapy research (5 papers). Ada G. Blidner is often cited by papers focused on Galectins and Cancer Biology (13 papers), Cancer Immunotherapy and Biomarkers (10 papers) and CAR-T cell therapy research (5 papers). Ada G. Blidner collaborates with scholars based in Argentina, United States and South Africa. Ada G. Blidner's co-authors include Gabriel A. Rabinovich, Santiago P. Méndez‐Huergo, Diego O. Croci, Alejandro J. Cagnoni, María T. Elola, Juan P. Cerliani, Marta A. Toscano, Bernardo L. Rapoport, Ronald Anderson and Karina V. Mariño and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Ada G. Blidner

29 papers receiving 894 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ada G. Blidner Argentina	18	591	381	307	67	59	30	899
Nadège Kindt Belgium	18	472 0.8×	242 0.6×	245 0.8×	60 0.9×	57 1.0×	30	856
Yuanming Xu United States	15	350 0.6×	353 0.9×	257 0.8×	67 1.0×	85 1.4×	17	918
Yulan Qing United States	11	311 0.5×	289 0.8×	276 0.9×	45 0.7×	65 1.1×	17	698
H. Mytrang United States	10	454 0.8×	378 1.0×	353 1.1×	84 1.3×	70 1.2×	14	963
Chunling Ma China	12	718 1.2×	237 0.6×	459 1.5×	63 0.9×	31 0.5×	29	1.1k
Luca Rubino Italy	10	827 1.4×	388 1.0×	455 1.5×	90 1.3×	78 1.3×	21	1.3k
Eleonora Timperi Italy	14	584 1.0×	311 0.8×	343 1.1×	52 0.8×	36 0.6×	22	977
Kristelle J. Capistrano United States	9	468 0.8×	352 0.9×	315 1.0×	75 1.1×	84 1.4×	16	931
Estrella Mariel Levy Argentina	22	857 1.5×	357 0.9×	743 2.4×	107 1.6×	69 1.2×	41	1.4k

Countries citing papers authored by Ada G. Blidner

Since Specialization

Citations

This map shows the geographic impact of Ada G. Blidner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ada G. Blidner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ada G. Blidner more than expected).

Fields of papers citing papers by Ada G. Blidner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ada G. Blidner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ada G. Blidner. The network helps show where Ada G. Blidner may publish in the future.

Co-authorship network of co-authors of Ada G. Blidner

This figure shows the co-authorship network connecting the top 25 collaborators of Ada G. Blidner. A scholar is included among the top collaborators of Ada G. Blidner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ada G. Blidner. Ada G. Blidner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Testa, Anna, William K. Kelly, Susan L. Bellis, et al.. (2025). A novel sialylation pathway mediated by extracellular vesicles in aggressive prostate cancer. PLoS ONE. 20(9). e0329014–e0329014.

Blidner, Ada G., Gabriel A. Rabinovich, Alessandro Fatatis, et al.. (2025). Exploring STEAP1 Expression in Prostate Cancer Cells in Response to Androgen Deprivation and in Small Extracellular Vesicles. Molecular Cancer Research. 23(6). 542–552. 2 indexed citations

Blidner, Ada G., et al.. (2023). 1466 Galectin-1 orchestrates a hierarchical tumor to stromal extracellular vesicles system that fosters immune suppression. SHILAP Revista de lepidopterología. A1630–A1630. 1 indexed citations

Abba, Martı́n C., Juan M. Pérez Sáez, Ada G. Blidner, et al.. (2023). Galectin-7 reprograms skin carcinogenesis by fostering innate immune evasive programs. Cell Death and Differentiation. 30(4). 906–921. 7 indexed citations

Cagnoni, Alejandro J., Ada G. Blidner, Rosa María Morales, et al.. (2021). Galectin-1 fosters an immunosuppressive microenvironment in colorectal cancer by reprogramming CD8 ⁺ regulatory T cells. Proceedings of the National Academy of Sciences. 118(21). 86 indexed citations

Anderson, Ronald, Ada G. Blidner, & Bernardo L. Rapoport. (2021). Frontiers in Pharmacology: Review Manuscript Targeting of the Neutrophil as an Adjunctive Strategy in Non-Small Cell Lung Cancer. Frontiers in Pharmacology. 12. 676399–676399. 10 indexed citations

Dalotto‐Moreno, Tomás, Pablo Andrés García, Ada G. Blidner, et al.. (2021). Hypoxia Supports Differentiation of Terminally Exhausted CD8 T Cells. Frontiers in Immunology. 12. 660944–660944. 61 indexed citations

Dougan, Michael, Ada G. Blidner, Jennifer Choi, et al.. (2020). Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of severe gastrointestinal and hepatic toxicities from checkpoint inhibitors. Supportive Care in Cancer. 28(12). 6129–6143. 31 indexed citations

Suarez‐Almazor, María E., Xerxes Pundole, Noha Abdel‐Wahab, et al.. (2020). Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of immune-mediated cardiovascular, rheumatic, and renal toxicities from checkpoint inhibitors. Supportive Care in Cancer. 28(12). 6159–6173. 14 indexed citations

10.

Blidner, Ada G., Jennifer Choi, Tim Cooksley, et al.. (2020). Cancer immunotherapy–related adverse events: causes and challenges. Supportive Care in Cancer. 28(12). 6111–6117. 25 indexed citations

11.

Shannon, Vickie R., Ronald Anderson, Ada G. Blidner, et al.. (2020). Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of immune-related adverse events: pulmonary toxicity. Supportive Care in Cancer. 28(12). 6145–6157. 16 indexed citations

12.

Choi, Jennifer, Ronald Anderson, Ada G. Blidner, et al.. (2020). Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of severe dermatological toxicities from checkpoint inhibitors. Supportive Care in Cancer. 28(12). 6119–6128. 21 indexed citations

13.

Cooksley, Tim, Monica Girotra, Pamela Ginex, et al.. (2020). Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of immune checkpoint inhibitor endocrinopathies and the role of advanced practice providers in the management of immune-mediated toxicities. Supportive Care in Cancer. 28(12). 6175–6181. 18 indexed citations

14.

Méndez‐Huergo, Santiago P., Ada G. Blidner, & Gabriel A. Rabinovich. (2017). Galectins: emerging regulatory checkpoints linking tumor immunity and angiogenesis. Current Opinion in Immunology. 45. 8–15. 125 indexed citations

15.

Wilson, Carlos, Ada G. Blidner, Christian González‐Billault, et al.. (2016). Ligand-mediated Galectin-1 endocytosis prevents intraneural H2O2 production promoting F-actin dynamics reactivation and axonal re-growth. Experimental Neurology. 283(Pt A). 165–178. 20 indexed citations

16.

Cerliani, Juan P., Ada G. Blidner, Marta A. Toscano, Diego O. Croci, & Gabriel A. Rabinovich. (2016). Translating the ‘Sugar Code’ into Immune and Vascular Signaling Programs. Trends in Biochemical Sciences. 42(4). 255–273. 88 indexed citations

17.

Ge, Xiao Na, et al.. (2016). Regulation of eosinophilia and allergic airway inflammation by the glycan-binding protein galectin-1. Proceedings of the National Academy of Sciences. 113(33). E4837–46. 51 indexed citations

18.

Sterle, Helena, Marı́a Laura Barreiro Arcos, Ada G. Blidner, et al.. (2015). The thyroid status reprograms T cell lymphoma growth and modulates immune cell frequencies. Journal of Molecular Medicine. 94(4). 417–429. 13 indexed citations

19.

Blidner, Ada G., Mariana Salatino, Iván Mascanfroni, et al.. (2015). Differential Response of Myeloid-Derived Suppressor Cells to the Nonsteroidal Anti-Inflammatory Agent Indomethacin in Tumor-Associated and Tumor-Free Microenvironments. The Journal of Immunology. 194(7). 3452–3462. 28 indexed citations

20.

Elola, María T., et al.. (2015). Assembly, organization and regulation of cell-surface receptors by lectin–glycan complexes. Biochemical Journal. 469(1). 1–16. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact